Scantlebery, A. M. L., Uil, M., Butter, L. M., Poelman, R., Claessen, N., Girardin, S. E., . . . Leemans, J. C. (2019). NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin. PLoS One.

Scantlebery, Angelique M. L., Melissa Uil, Loes M. Butter, Renée Poelman, Nike Claessen, Stephen E. Girardin, Sandrine Florquin, Joris J. T. H. Roelofs, e Jaklien C. Leemans. "NLRX1 Does Not Play a Role in Diabetes nor the Development of Diabetic Nephropathy Induced By Multiple Low Doses of Streptozotocin." PLoS One 2019.

Scantlebery, Angelique M. L., et al. "NLRX1 Does Not Play a Role in Diabetes nor the Development of Diabetic Nephropathy Induced By Multiple Low Doses of Streptozotocin." PLoS One 2019.